Drug Delivery
Single-Domain Antibodies and Variants Thereof Against Fibroblast Activation Protein
WARF: P230173US02
Inventors: Aaron LeBeau, Joseph Gallant
The Invention
UW-Madison researchers have developed a camelid antibody domain that binds human fibroblast activation protein (FAP) with low nanomolar affinity. FAP is expressed in 90% of all solid tumors making it an attractive target for imaging or delivering drugs to tumors.
Additional Information
For More Information About the Inventors
Tech Fields
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847